UPLOAD Filing
Benitec Biopharma Inc.
Date: Feb. 6, 2026 · CIK: 0001808898 · Accession: 0000000000-26-001290
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293077
Letter
February 6, 2026 Jerel Banks Chief Executive Officer Benitec Biopharma Inc. 3940 Trust Way Hayward, CA 94545 Re:Benitec Biopharma Inc. Registration Statement on Form S-3 Filed January 30, 2026 File No. 333-293077 Dear Jerel Banks: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Matthew S. O'Loughlin, Esq.
Show Raw Text
February 6, 2026
Jerel Banks
Chief Executive Officer
Benitec Biopharma Inc.
3940 Trust Way
Hayward, CA 94545
Re:Benitec Biopharma Inc.
Registration Statement on Form S-3
Filed January 30, 2026
File No. 333-293077
Dear Jerel Banks:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Matthew S. O'Loughlin, Esq.